Detalhe da pesquisa
1.
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Lancet
; 395(10233): 1374-1381, 2020 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334703
2.
Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study.
Eur J Clin Pharmacol
; 75(9): 1201-1210, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197411
3.
Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS-AMI trials.
Am Heart J
; 194: 73-82, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29223437
4.
Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE study.
Am Heart J
; 170(5): 981-985.e1, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542508
5.
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.
Am Heart J
; 168(1): 16-22.e1, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952855